Kamata Y - Search Results

1

Identification of HLA class I-binding peptides derived from unique cancer-associated proteins by mass spectrometric analysis.

Kamata Y, Kuhara A, Iwamoto T, Hayashi K, Koido S, Kimura T, Egawa S, Homma S. Kamata Y, et al. Anticancer Res. 2013 May;33(5):1853-9. Anticancer Res. 2013. PMID: 23645730

2

Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer.

Koido S, Homma S, Okamoto M, Takakura K, Mori M, Yoshizaki S, Tsukinaga S, Odahara S, Koyama S, Imazu H, Uchiyama K, Kajihara M, Arakawa H, Misawa T, Toyama Y, Yanagisawa S, Ikegami M, Kan S, Hayashi K, Komita H, Kamata Y, Ito M, Ishidao T, Yusa S, Shimodaira S, Gong J, Sugiyama H, Ohkusa T, Tajiri H. Koido S, et al. Among authors: kamata y. Clin Cancer Res. 2014 Aug 15;20(16):4228-39. doi: 10.1158/1078-0432.CCR-14-0314. Epub 2014 Jul 23. Clin Cancer Res. 2014. PMID: 25056373 Clinical Trial.

3

Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression in human gastrointestinal stromal tumors.

Komita H, Koido S, Hayashi K, Kan S, Ito M, Kamata Y, Suzuki M, Homma S. Komita H, et al. Among authors: kamata y. Oncol Rep. 2015 Oct;34(4):2099-105. doi: 10.3892/or.2015.4149. Epub 2015 Jul 24. Oncol Rep. 2015. PMID: 26239720

4

A Novel Near-infrared Fluorescent Protein, iRFP720, Facilitates Transcriptional Profiling of Prostate Cancer Bone Metastasis in Mice.

Honda M, Yogosawa S, Kamada M, Kamata Y, Kimura T, Koike Y, Harada T, Takahashi H, Egawa S, Yoshida K. Honda M, et al. Among authors: kamata y. Anticancer Res. 2017 Jun;37(6):3009-3013. doi: 10.21873/anticanres.11655. Anticancer Res. 2017. PMID: 28551639

5

Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells.

Homma S, Hayashi K, Yoshida K, Sagawa Y, Kamata Y, Ito M. Homma S, et al. Among authors: kamata y. Int Immunopharmacol. 2018 Jan;54:39-45. doi: 10.1016/j.intimp.2017.10.016. Epub 2017 Oct 28. Int Immunopharmacol. 2018. PMID: 29100036

6

Claudin 7 as a possible novel molecular target for the treatment of pancreatic cancer.

Okui N, Kamata Y, Sagawa Y, Kuhara A, Hayashi K, Uwagawa T, Homma S, Yanaga K. Okui N, et al. Among authors: kamata y. Pancreatology. 2019 Jan;19(1):88-96. doi: 10.1016/j.pan.2018.10.009. Epub 2018 Nov 2. Pancreatology. 2019. PMID: 30416041

7

Expression of ERG oncoprotein is associated with a less aggressive tumor phenotype in Japanese prostate cancer patients.

Kimura T, Furusato B, Miki J, Yamamoto T, Hayashi N, Takahashi H, Kamata Y, van Leenders GJ, Visakorpi T, Egawa S. Kimura T, et al. Among authors: kamata y. Pathol Int. 2012 Nov;62(11):742-8. doi: 10.1111/pin.12006. Pathol Int. 2012. PMID: 23121605

8

Augmentation of antitumor immunity by fusions of ethanol-treated tumor cells and dendritic cells stimulated via dual TLRs through TGF-β1 blockade and IL-12p70 production.

Koido S, Homma S, Okamoto M, Namiki Y, Takakura K, Takahara A, Odahara S, Tsukinaga S, Yukawa T, Mitobe J, Matsudaira H, Nagatsuma K, Kajihara M, Uchiyama K, Arihiro S, Imazu H, Arakawa H, Kan S, Hayashi K, Komita H, Kamata Y, Ito M, Hara E, Ohkusa T, Gong J, Tajiri H. Koido S, et al. Among authors: kamata y. PLoS One. 2013 May 24;8(5):e63498. doi: 10.1371/journal.pone.0063498. Print 2013. PLoS One. 2013. PMID: 23717436 Free PMC article.

9

Vaccination with vascular progenitor cells derived from induced pluripotent stem cells elicits antitumor immunity targeting vascular and tumor cells.

Koido S, Ito M, Sagawa Y, Okamoto M, Hayashi K, Nagasaki E, Kan S, Komita H, Kamata Y, Homma S. Koido S, et al. Among authors: kamata y. Cancer Immunol Immunother. 2014 May;63(5):459-68. doi: 10.1007/s00262-014-1531-1. Epub 2014 Mar 14. Cancer Immunol Immunother. 2014. PMID: 24627093 Free PMC article.

10

Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine.

Kan S, Koido S, Okamoto M, Hayashi K, Ito M, Kamata Y, Komita H, Ishidao T, Nagasaki E, Homma S. Kan S, et al. Among authors: kamata y. Oncol Rep. 2015 Jul;34(1):504-10. doi: 10.3892/or.2015.3974. Epub 2015 May 12. Oncol Rep. 2015. PMID: 25976081

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

455 results

Search Page